This review uncovers infection mechanisms using innovative surface labeling techniques, implying new therapeutic approaches.
Understanding molecular interactions at the host–pathogen interface is essential to decipher infection mechanisms and develop new therapies. Bacterial surface proteins and host‐derived bacterial binding proteins (HBBPs) govern colonization, adhesion, and immune modulation, but are difficult to study due to low abundance and transient interactions. Advances in chemical biology and proteomics now enable high‐resolution mapping of these dynamic surfaces. Techniques such as bioorthogonal labeling, photo‐crosslinking, click chemistry, and enzymatic proximity labeling expand our ability to identify surface‐exposed and transient complexes. Combined with mass spectrometry and bioinformatics, they offer an integrated view of host–microbe crosstalk, revealing novel virulence factors and antigenic targets. This review highlights innovative labeling strategies advancing infection biology and immune recognition.
No takes yet. Share an insight, caveat, or question.
Dubois et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: